Trials / Unknown
UnknownNCT03070405
The Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects
An Open-label, Randomized, Crossover Study to Evaluate the Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Inje University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to evaluate whether PAS will change the PK parameters of tenofovir.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tenofovir disoproxil fumarate 300mg | Single oral dose on the first day of each period |
| DRUG | Para-aminosalicylic acid Ca granule 5.28 g | Twice daily oral administration from the first day of each period to the seventh dose |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-03-01
- Completion
- 2017-05-01
- First posted
- 2017-03-03
- Last updated
- 2017-03-03
Source: ClinicalTrials.gov record NCT03070405. Inclusion in this directory is not an endorsement.